Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Linagliptin may cause hair loss and skin blisters.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Upadacitinib may effectively treat alopecia areata without side effects.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Baricitinib effectively treated hair loss and inflammation in a patient with alopecia areata and lichen planopilaris.

CTP-543 is generally safe for treating alopecia areata.

Pexidartinib often causes liver issues and fatigue, especially in women.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Erlotinib can cause nonscarring hair loss and itchy skin.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.